Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.
about
Evaluation of the risks of chemotherapy in dogs with thrombocytopenia.Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia(®)) in Dogs with Spontaneous Malignancies.Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcomaAntiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitroA pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.Kinase dysfunction and kinase inhibitors.The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumours in vitro.Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.Comparison between Ki-67 index and mitotic index for predicting outcome in canine mast cell tumours.Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs.
P2860
Q33421905-F58F62CA-5FCC-433D-A7EE-CB76A920A49DQ33428144-5B0EC554-069A-48DE-BED4-02D52C363A7BQ33726782-39FAB20F-127B-4995-9541-8F50231B2F5BQ35660360-FFF73FE8-8659-4595-AE15-16E3F9DA28D0Q36040399-2A2606CF-E058-4652-8FEA-E483239D0A79Q36195537-A9CE222E-B2E8-4FF0-96E7-A2E7FDF76C18Q36974779-981CF203-9380-439F-B03C-6019B400D700Q38075152-19C77AF2-BD79-43CD-AD0F-2740C36C86F9Q39140093-1DF932DF-4C54-4F46-9E50-E6808E928C40Q48254839-1E4055B5-370C-4330-A952-F42844B5AA19Q52681024-DF9EB157-320B-4EB6-A526-AC954DA28800Q53232375-FBBE6332-1A28-4B8B-B256-68C3E8E1A4D2Q54978288-7694C7AB-D8F0-4987-81D6-59C25511F314
P2860
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety evaluation of combinati ...... a phase I dose-finding study.
@en
Safety evaluation of combination vinblastine and toceranib phosphate
@nl
type
label
Safety evaluation of combinati ...... a phase I dose-finding study.
@en
Safety evaluation of combination vinblastine and toceranib phosphate
@nl
prefLabel
Safety evaluation of combinati ...... a phase I dose-finding study.
@en
Safety evaluation of combination vinblastine and toceranib phosphate
@nl
P2093
P2860
P1476
Safety evaluation of combinati ...... a phase I dose-finding study.
@en
P2093
L McCartan
P2860
P304
P356
10.1111/J.1476-5829.2011.00261.X
P577
2011-01-31T00:00:00Z